Defining a Space for NRG1 Fusion–Positive Tumors in Lung and GI Cancers
Cancer Network,
Meet the experts A group of lung and gastrointestinal (GI) cancer experts gathered during a Frontline Forum event to discuss…
Meet the experts A group of lung and gastrointestinal (GI) cancer experts gathered during a Frontline Forum event to discuss…
Blocking ligand interaction of HER2 and HER3 in patients with NRG1 fusion–positive tumors has demonstrated a clinically…
Early data have demonstrated poor outcomes for patients with NRG1 fusions, and limited efficacy with available treatments…
D. Ross Camidge, MD, PhD, and Alexander I. Spira, MD, PhD, discussed the use of NRG1 fusions as being a driver for patients…